Poland has Billions of € to be granted for innovation; such money must be spent in Poland and you need to open a “nexus” (Polish R&D subsidiary). This is good for Poland, and will increase foreign direct investments (FDI), and for the Israeli companies that can find matching R&D skills there. We are now launching the first “nexus” to develop a small non-invasive ear-VNS treatment of cognitive impairment degeneration / Alzheimer’s Disease @ Home: Cogniguard.

Animal studies are conducted in Lodz.